Newsroom

CHARLOTTE, N.C.--(BUSINESS WIRE)--Barings, one of the world’s leading global alternative investment managers, today announced the successful close of over $19 billion in committed capital for its Global Direct Lending strategy, garnering interest from a diverse group of institutional, insurance and wealth clients. The two-year fundraising period coincided with strong and sustained deployment activity, including over $18 billion across 355 transactions globally. “We are thrilled to reach this mi...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) announces that its Annual General Meeting (AGM) is to be held in London on 26 June 2026. Full details of the AGM and proposed resolutions are available on the Company’s Investor Relations website: https://investors.polestar.com/corporate-governance/annual-general-meeting The meeting will be voting for the re-appointment of all Directors and the appointment of PricewaterhouseCoopers as Auditors. About Polestar Polestar (Nasdaq: PSNY) i...

COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, today announced the acquisition of Diamond Energy Systems, Inc. (“DESI”). With headquarters in St. Joseph, MN, DESI specializes in mechanical insulation with the majority of its sales derived from retrofit work between industrial and commercial applications. “DESI adds approximately $12 million of annual revenue...

MILWAUKEE--(BUSINESS WIRE)--LiveWire Group, Inc. (NYSE: LVWR), a leader in the electric two‑wheel industry, today announced it has acquired the assets of Dust Moto, bringing deep off‑road knowledge and expertise to LiveWire, thereby marking a strategic expansion into the electric off‑road segment. The acquisition strengthens LiveWire’s strategy to grow beyond on‑road electric motorcycles and address the rapidly expanding electric off‑road market, which is being driven by riders seeking incredib...

SPRINGFIELD, Mass. & BOSTON--(BUSINESS WIRE)--MassMutual today announced the launch of its Living Well Rider, a value-added benefit automatically included on eligible new whole life insurance policies that gives policyowners access to a suite of wellness tools designed to support long-term physical and mental well-being. The Living Well Rider provides eligible policyowners with access to the following at no additional cost: The Galleri® multi-cancer early detection test by GRAIL Genetic risk as...

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Parent Company”), a leading AI humanoid robot manufacturer for social tasks, is pleased to provide an update on its previously announced transaction to list Realbotix LLC (“RealLLC” or the “Subsidiary”), a wholly owned subsidiary of Realbotix, on the Nasdaq Capital Market via a reverse takeover transaction with Onconetix, Inc. (NASDAQ: ONCO) (“ONCO”). The proposed transaction will res...

CAMDEN, N.J.--(BUSINESS WIRE)--The Campbell’s Company (NASDAQ:CPB) (Campbell’s) announced it will report its financial results for the third quarter fiscal 2026 ended May 3, 2026 on June 8, 2026. A press release, slide presentation, transcript and audio of pre-recorded management remarks will be available at 7:15 a.m. ET. Mick Beekhuizen, President and Chief Executive Officer, and Todd Cunfer, Executive Vice President and Chief Financial Officer will host a live question-and-answer session at 9...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated commercial-stage immunotherapy company, today announced results from two indirect treatment comparison (ITC) analyses presented at the 2026 American Urological Association (AUA) Annual Meeting evaluating nogapendekin alfa inbakicept-pmln (NAI, ANKTIVA®) plus Bacillus Calmette–Guérin (BCG) against two other U.S. Food and Drug Administration (FDA) approved therapies for patients with BCG-unresponsive n...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced that it has received a successful response to its recent Type C meeting request from the U.S. Food and Drug Administration (FDA), focused on the ongoing Phase 2 HARMONIC™ trial of LP-300 in never-smokers with advanced non-small cell lung cancer (NSCLC) adenocarcinoma. In its written responses to Lantern's Type C meeting request, the FDA raised no objections to key...

ROANOKE, Va.--(BUSINESS WIRE)--KlariVis has been named one of American Banker's 2026 Best Places to Work in Fintech for the fourth consecutive year....